On 24 October 2021, Llorenç Rafecas, founder of the pharmaceutical company Enantia and President of “El Centre”, interviewed ICMAB researcher Judith Guasch in the framework of the “Cicle de Ciència i Futur” organized by “El Centre”; a cultural center of Llorenç del Penedès. Judith explained her personal experience as a researcher and her developments in the field of biomaterials for cancer immunotherapy.
Institute of Materials Science of Barcelona (ICMAB-CSIC)
Til·lers, s/n, Campus de la UAB, 08193 Bellaterra, Spain
Tel. +34 93 5801853
Max Planck Institute for Medical Research
Jahnstraße 29, 69120 Heidelberg, Germany